|
Index of reports
> Cases resulting in hospitalization (146)
Below is the selection of adverse event reports related to Carbamazepine that includes cases resulting in hospitalization.
Reports 1 - 25 of 146 Next >>
Adverse event in 65 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Italy on 2007-10-31
Patient: 65 year old female
Adverse reactions / side effects: Respiratory Rate Increased, Glossodynia, Ataxia, Somnolence, Diplopia, Oral Pain, Visual Disturbance, Anticonvulsant Drug Level Increased, Dizziness
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 300 mg tid
Indication: Glossodynia
Carbamazepine
Dosage: 200 mg tid
Indication: Glossodynia
Adverse event in 40 year old male receiving Carbamazepine
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-23
Patient: 40 year old male
Adverse reactions / side effects: Agitation, Confusional State, Pyrexia, Treatment Noncompliance, Grand MAL Convulsion, Encephalitis Herpes, Disturbance in Attention, Memory Impairment, Hypogammaglobulinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in 24 year old male receiving Carbamazepine
Reported by a physician from Japan on 2007-10-22
Patient: 24 year old male
Adverse reactions / side effects: Agitation, Dysphagia, Abasia, Torticollis, Somnolence, Aggression, Incontinence, Aspartate Aminotransferase Increased, Salivary Hypersecretion, Neuroleptic Malignant Syndrome, Blood Pressure Fluctuation
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 400 mg, oral, 600 mg, oral
Administration route: Oral
Zonegran
Dosage: 160 mg, oral, gradual increase from 160mg to 300mg; oral, 300mg, oral
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Risperidone; Clonazepam
Adverse event in male receiving Carbamazepine
Reported by a physician from Korea, Republic of on 2007-10-19
Patient: male, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Drug Ineffective, Dizziness, Blood Sodium Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: daily dose:1000mg
Indication: Epilepsy
Start date: 2007-01-29
End date: 2007-04-27
Lyrica
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Valproic Acid; Topiramate; Astrix
Adverse event in 24 year old female receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-10-19
Patient: 24 year old female
Adverse reactions / side effects: Dysarthria, Partial Seizures, Apraxia, Central Nervous System Lesion, Motor Dysfunction, Amnesia
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 800 mg/day
Indication: Partial Seizures
Carbamazepine
Dosage: 1200 mg/day
Adverse event in 35 year old male receiving Carbamazepine
Reported by a pharmacist from United States on 2007-10-18
Patient: 35 year old male, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Drug Level Increased, Somnolence, Aggression
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in female receiving Carbamazepine
Reported by a physician from France on 2007-10-18
Patient: female
Adverse reactions / side effects: Intentional Overdose, Suicide Attempt, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Carbamazepine
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-11
End date: 2007-07-11
Epilim Tablet
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-11
End date: 2007-07-11
Adverse event in 36 year old female receiving Carbamazepine
Reported by a physician from United States on 2007-10-18
Patient: 36 year old female
Adverse reactions / side effects: Neuroleptic Malignant Syndrome
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Carbamazepine
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Clonazepam
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Gabapentin
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Levetiracetam
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Metoclopramide
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-01
End date: 2007-01-01
Phenytoin
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Primidone
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Unknown Neuroleptics()
End date: 2007-01-01
Valproic Acid
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Venlafaxine HCL
Indication: Convulsion
Start date: 2007-01-01
End date: 2007-01-01
Adverse event in 88 year old male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-18
Patient: 88 year old male, weighing 79.4 kg (174.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in female receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-17
Patient: female
Adverse reactions / side effects: Drug Level Above Therapeutic, Encephalopathy, Disorientation, Somnolence, Hallucination
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Administration route: Oral
Indication: Epilepsy
Depakene
Administration route: Oral
Indication: Epilepsy
End date: 2007-01-01
Depakene
Administration route: Oral
Start date: 2007-01-01
Other drugs received by patient: Levothyroxine Sodium
Adverse event in 15 year old female receiving Carbamazepine
Reported by a consumer/non-health professional from United States on 2007-10-16
Patient: 15 year old female
Adverse reactions / side effects: Productive Cough, Anticonvulsant Drug Level Above Therapeutic, Retching, Depressed Level of Consciousness, Pharmaceutical Product Complaint, Amnesia, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in 40 year old male receiving Carbamazepine
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-16
Patient: 40 year old male
Adverse reactions / side effects: Encephalitis Herpes, Herpes Simplex, Erythema Multiforme, Hypogammaglobulinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Indication: Drug USE FOR Unknown Indication
Phenytoin
Dosage: intravenous
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Aciclovir (Aciclovir) (Aciclovir); Cefotaxime (Cefotaxime) (Cefotaxime)
Adverse event in 28 year old male receiving Carbamazepine
Reported by a individual with unspecified qualification from Bulgaria on 2007-10-16
Patient: 28 year old male
Adverse reactions / side effects: Pneumonia, Haemophilus Infection, Toxic Epidermal Necrolysis, Sputum Culture Positive, Drug Rash With Eosinophilia and Systemic Symptoms, Hepatosplenomegaly
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Other drugs received by patient: Clonidine; Diazepam; Alcohol
Adverse event in 32 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Brazil on 2007-10-15
Patient: 32 year old female
Adverse reactions / side effects: Cholestasis, Condition Aggravated, Depression, Hepatitis, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Amitriptyline HCL
Dosage: 50 mg, (50 mg, 1 in 1 d); oral
Administration route: Oral
Indication: Depression
Start date: 2005-09-27
End date: 2005-10-12
Carbamazepine
Dosage: 800 mg (400 mg, 2 in 1 d); oral
Administration route: Oral
Indication: Convulsion
Start date: 2005-09-22
End date: 2005-10-17
Chlorpromazine
Dosage: 50 mg (50 mg, 1 in 1 d); intravenous (not otherwise specified)
Indication: Depression
Start date: 2005-09-21
End date: 2005-09-26
Copaxone
Dosage: 20 mg (20 mg, 1-2) subcutaneous, 20 mg (20 mg, 1 in 1 d), subcutaneous
Indication: Multiple Sclerosis
Start date: 2005-09-29
End date: 2005-10-17
Copaxone
Dosage: 20 mg (20 mg, 1-2) subcutaneous, 20 mg (20 mg, 1 in 1 d), subcutaneous
Indication: Multiple Sclerosis
Start date: 2005-10-31
Fluoxetine
Dosage: 20 mg (20 mg, 1 in 1 d); oral
Administration route: Oral
Indication: Depression
Start date: 2005-06-27
End date: 2005-09-02
Interferon Beta
Dosage: double blind: 250 or 500 microgram
Indication: Relapsing-Remitting Multiple Sclerosis
Start date: 2005-07-25
End date: 2005-09-22
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified)
Indication: Convulsion
Start date: 2005-09-16
End date: 2005-09-16
Phenytoin
Dosage: 300 mg (300 mg, 1 in 1 d); oral, 300 mg (300 mg, 1 in 1 d); oral
Administration route: Oral
Start date: 2005-09-17
End date: 2005-09-18
Phenytoin
Dosage: 300 mg (300 mg, 1 in 1 d); oral, 300 mg (300 mg, 1 in 1 d); oral
Administration route: Oral
Start date: 2005-09-20
End date: 2005-09-21
Other drugs received by patient: Diane; Captopril; Diazepam; Belacodid; Prednisone; Diclofenac; Sertraline; Clonazepam; Ibuprofen; Paracetamol; Dimenhydrinate; Dipyron; Tramadol HCL; Metoclopramide; Ranitidine HCL; Sodium Chloride
Adverse event in 24 year old male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-15
Patient: 24 year old male
Adverse reactions / side effects: Agitation, Blood Creatine Phosphokinase Increased, Abasia, Drug Interaction, Muscle Spasticity, Pyrexia, Hyperhidrosis, Muscle Rigidity, Somnolence, Labile Blood Pressure, Incontinence, Choreoathetosis, Neuroleptic Malignant Syndrome, Salivary Hypersecretion, Dysphagia, Torticollis, Aggression, Heart Rate Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 400 mg/day
Indication: Partial Seizures
Carbamazepine
Dosage: 600 mg/day
Zonisamide
Dosage: 160 to 300 mg/day
Zonisamide
Dosage: 300 mg/day
Other drugs received by patient: Risperidone; Clonazepam
Adverse event in 70 year old male receiving Carbamazepine
Reported by a pharmacist from United States on 2007-10-10
Patient: 70 year old male
Adverse reactions / side effects: Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in 40 year old male receiving Carbamazepine
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-09
Patient: 40 year old male
Adverse reactions / side effects: Grand MAL Convulsion, Anterograde Amnesia, Agitation, Encephalitis Herpes, Treatment Noncompliance, Hypogammaglobulinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in 59 year old male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Poland on 2007-10-08
Patient: 59 year old male
Adverse reactions / side effects: Nausea, Hyponatraemia, Extensor Plantar Response, Convulsion, Blood Creatinine Decreased, Blood Osmolarity Decreased, Blood Uric Acid Decreased, Urine Osmolarity Increased, Anorexia, Inappropriate Antidiuretic Hormone Secretion, Extrapyramidal Disorder, Hyporeflexia, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 200 mg/day
Indication: Trigeminal Neuralgia
Carbamazepine
Dosage: 600 mg/day in 2 divided doses
Other drugs received by patient: Hydrochlorothiazide; Amlodipine
Adverse event in 59 year old male receiving Carbamazepine
Reported by a individual with unspecified qualification on 2007-10-08
Patient: 59 year old male
Adverse reactions / side effects: Facial Neuralgia, Drug Ineffective, Inappropriate Antidiuretic Hormone Secretion, Brain Oedema, Hyponatraemia, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Amlodipine
Indication: Hypertension
Carbamazepine
Indication: Facial Neuralgia
Hydrochlorothiazide
Indication: Hypertension
Other drugs received by patient: Bisoprolol Fumarate
Adverse event in 6 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient: 6 year old female
Adverse reactions / side effects: Drug Hypersensitivity, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Prothrombin Time Prolonged, Respiratory Distress, Drug Rash With Eosinophilia and Systemic Symptoms, Ascites, Gamma-Glutamyltransferase Increased, Hypoproteinaemia, Aspartate Aminotransferase Increased, Pleural Effusion, Hypoalbuminaemia, Bilirubin Conjugated Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Carbamazepine
Adverse event in 75 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-03
Patient: 75 year old female
Adverse reactions / side effects: Multi-Organ Failure, Pneumonia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Carbamazepine
Administration route: Oral
Indication: Bipolar Disorder
Periciazine
Administration route: Oral
Indication: Bipolar Disorder
Sertraline HCL
Administration route: Oral
Indication: Depression
Adverse event in 32 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Brazil on 2007-10-01
Patient: 32 year old female
Adverse reactions / side effects: Hepatic Enzyme Abnormal, Hepatic Function Abnormal, Pyoderma, Cholestasis, Hepatitis, Septic Shock, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Amitriptyline HCL
Dosage: 50 mg (50 mg, 1 in 1 d)
Administration route: Oral
Indication: Depression
Start date: 2005-09-27
End date: 2005-10-12
Carbamazepine
Dosage: 800 mg (400 mg, 2 in 1 d)
Administration route: Oral
Indication: Convulsion
Start date: 2005-09-22
End date: 2005-10-17
Chlorpromazine
Dosage: 50 (50 mg, 1 in 1 d) intravenous (not otherwise specified)
Indication: Depression
Start date: 2005-09-21
End date: 2005-09-26
Copaxone
Dosage: 20 mg (20 mg, 1 in 1 d)
Indication: Multiple Sclerosis
Start date: 2005-09-29
End date: 2005-10-22
Fluoxetine
Dosage: 20 mg (20 mg, 1 in 1 d)
Administration route: Oral
Indication: Depression
Start date: 2005-06-27
End date: 2005-09-02
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-16
End date: 2005-09-16
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-17
End date: 2005-09-18
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-20
End date: 2005-09-21
Other drugs received by patient: Diane; Captopril; Diazepam; Belacodid; Prednisone; Diclofenac Sodium; Sertraline; Clonazepam; Ibuprofen; Paracetamol; Dimenhydrinate; Dipyron; Tramadol HCL; Metoclopramide; Ranitidine HCL; Sodium Chloride
Adverse event in 25 year old male receiving Carbamazepine
Reported by a consumer/non-health professional from Israel on 2007-10-01
Patient: 25 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Pneumonia Aspiration, Intentional Overdose, Coma, Hypernatraemia, Somnolence, Loss of Consciousness, Gamma-Glutamyltransferase Increased, Thrombocytopenia, Vomiting, Mydriasis, Alanine Aminotransferase Increased, Convulsion, Anticonvulsant Drug Level Above Therapeutic, Sepsis, Sinus Tachycardia, Leukocytosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 20g per day
Administration route: Oral
Indication: Borderline Personality Disorder
Paroxetine
Dosage: 400mg per day
Administration route: Oral
Indication: Borderline Personality Disorder
Other drugs received by patient: Lithium; Risperidone
Adverse event in 75 year old female receiving Carbamazepine
Reported by a physician from Germany on 2007-07-31
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Vomiting, Overdose, Nausea, Vestibular Disorder, Vertigo, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Dosage: 300 mg, qd
Administration route: Oral
Indication: Trigeminal Neuralgia
Start date: 2007-03-26
Carbamazepine
Dosage: 300 mg, bid
Administration route: Oral
Lyrica
Dosage: 75 mg, tid
Administration route: Oral
Indication: Trigeminal Neuralgia
Start date: 2004-01-01
Lyrica
Dosage: 150 mg, tid
Administration route: Oral
Zoledronic Acid
Dosage: 5 mg, once yearly
Indication: Osteoporosis
Start date: 2007-01-11
Other drugs received by patient: Omeprazole; Lorzaar Plus; Amlodipine; Euthyrox; Aspirin; Locol; Melperon; Rivotril; Magnesium Verla; Diclofenac Sodium; Lidocain; Ambene FOR Injection; Piroxicam ^ratiopharm^; Diclofenac ^ratiopharm^; Triam; Calcivit D
Adverse event in 74 year old male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-30
Patient: 74 year old male
Adverse reactions / side effects: Mania, Bipolar I Disorder, Condition Aggravated, Major Depression
Adverse event resulted in: hospitalization
Suspect drug(s):
Carbamazepine
Page 1 Next >>
|
